Joseph Gentile brings over 30 years of business experience to the team.
Joe’s career as an operating executive, board member and investor has spanned medical devices, diagnostics, life science tools and cell therapy platforms and services.
He began his career in early-stage startups, later moving to HP Medical Products Group (now Philips Medical Systems) where he spent 10 years in engineering, marketing and corporate strategy roles.
Following HP, Joe spent 14 years at Becton Dickinson in corporate strategy, global business unit general management, and corporate venture investments.
Recently, Joe was CEO and board member at Cellero Biosciences (acquired by Charles River Labs) and Stemgent Inc (acquired by ReproCell Group of Japan).
Joe is an active angel investor and has investments in companies at the forefront of cell therapy and life science tools, diagnostics, and green technologies.
To be provided